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Abstract 
Purpose: To evaluate the relative importance and predictive 
ability of salivary IgA (s-IgA) measures with regards to upper 
respiratory illness (URI) in youth athletes. Methods: Over a 38-
week period, twenty-two youth athletes (age 16.8; ±0.5 years) 
provided daily symptoms of URI and fifteen fortnightly passive 
drool saliva samples, from which s-IgA concentration and 
secretion rate were measured. Kernel smoothed bootstrapping 
generated a balanced dataset with simulated data points. The 
random forest algorithm was used to evaluate the relative 
importance (RI) and predictive ability of s-IgA concentration 
and secretion rate with regards to URI symptoms present on the 
day of saliva sampling (URIday), within two weeks of sampling 
(URI2wk) and within four weeks of sampling (URI4wk). Results: 
The percentage deviation from average healthy s-IgA 
concentration was the most important feature for URIday (median 
RI 1.74, interquartile range 1.41-2.07). The average healthy s-
IgA secretion rate was the most important feature within URI4wk 
(median RI 0.94, interquartile range 0.79-1.13). No feature was 
clearly more important than any other in URI2wk. The median 
area under the curve values were 0.68, 0.63 and 0.65 for URIday, 
URI2wk and URI4wk respectively. Conclusions: The RI values 
suggest the percentage deviation from average healthy s-IgA 
concentration may be used to evaluate the short-term risk of 
URI, whilst the average healthy s-IgA secretion rate may be used 
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to evaluate the long-term risk. However, the results show that 
neither s-IgA concentration nor secretion rate can be used to 
accurately predict URI onset within a four-week window in 
youth athletes. 




The negative impact of illness on performance, and the 
mechanisms by which athletic development could be hindered, 
are now well established1–3. Illness usually occurs within a 
sporting situation when the immune response to a pathogen is 
compromised4–7. It has recently been documented that 
psychological stress affects this immune response by a similar 
magnitude when compared to physical stress8. Given that youth 
athletes are subjected to a unique set of academic, maturational 
and social stressors alongside their sporting demands (i.e. their 
training/match load and associated travel requirements)9, and 
that their stress coping skills do not fully develop until 
adulthood10, there is significant scope for the combined effect of 
these physical and psychological stressors to place them at 
significant risk of illness incidence in high performance sporting 
environments11,12. Consequently, in an effort to maximise youth 
athlete development and performance, regular monitoring of the 
risk of upper respiratory illness (URI) has been encouraged13. 
Despite this, only one study has evaluated the risk of URI in 
youth athletes14, as the majority of studies in the area have 
focussed on collegiate5,7 or professional4,6 athletes. 
One method of assessing a youth athlete’s risk of URI is via 
assessment of their salivary Immunoglobulin A (s-IgA)7,15. In 
recent years, the use of s-IgA as an URI monitoring strategy has 
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increased as it provides a relatively non-invasive and objective 
measure of athlete immune function16,17. IgA is the predominant 
antibody secreted by the mucosa as part of the ‘first line of 
defence’ against the vast majority of infections attempting to 
invade the human body17,18, so it is unsurprising that some 
studies have associated reductions in s-IgA with an increased 
risk of URI incidence4–6. However, this association has not 
always been replicated7,14 and the true predictive ability of s-IgA 
with regards to URI incidence remains unclear5–7.  
Some of the discrepancy in findings between s-IgA studies can 
be accounted for by the data collection methods used. S-IgA can 
be measured as either a concentration5,6 or a secretion rate5,7, and 
it is possible that both measures are important at different time 
points prior to URI incidence. For example, a significant 
transient weekly reduction in s-IgA concentration in the three 
weeks prior to URI incidence has been reported in elite adult 
yachtsmen6, but no significant difference in s-IgA secretion rate 
was observed on a similar weekly basis in female collegiate 
soccer players7. Similarly, although s-IgA secretion rate was 
associated with an increased risk of URI in collegiate American 
football players, s-IgA concentration was not in the four weeks 
or greater time period between sampling points5. Taken together, 
the results of these studies suggest that s-IgA concentration may 
be a more important short-term predictor of URI, with a 
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declining importance up to three weeks prior to URI onset. 
Conversely, s-IgA secretion rate may be a more important long-
term predictor of URI (four weeks and greater prior to onset). 
However, no study has proven this hypothesis so a study 
considering the relative importance of s-IgA concentration and 
secretion rate as predictors of URI at different time points in the 
four weeks prior to onset is warranted. 
Alongside a greater understanding of the relative importance of 
s-IgA concentration and secretion rate at different time points
prior to URI onset, it would be beneficial to elucidate the true 
predictive ability of s-IgA with regards to URI incidence. 
Although a three week transient drop in s-IgA concentration 
below the individual’s average healthy value (averaged from all 
those values where URI was not present) was associated with 
URI incidence in elite adult yachtsmen, the same study found 
that only 28% of the samples identifying a drop in s-IgA 
concentration below 70% of this value resulted in subsequent 
URI incidence6. Similarly, only 48% of the samples falling 
below 40% of the average healthy s-IgA concentration resulted 
in future URI incidence. Furthermore, although s-IgA secretion 
rate was the only significant measure in the regression model for 
collegiate American football players, the model over-predicted 
URI incidence at each sampling point and s-IgA secretion rate 
accounted for only 12-42% of the variance in URI incidence5. It 
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has recently been shown within injury prevention research that 
training load variables demonstrating strong associations with 
injury incidence are not necessarily strong predictors of injury 
timing19,20, so it is pivotal that the true predictive ability of 
immune measures with regards to URI is fully evaluated. 
To understand the true relative importance and predictive ability 
of s-IgA with regards to URI in youth athletes, it is necessary to 
shift from a data modelling or correlation-based approach (e.g. 
mixed effects models or regressions) to a machine learning or 
prediction-based approach (e.g. decision trees or random 
forests)21. The key difference between these two approaches is 
the method by which they are optimised. Correlation-based 
approaches are optimised to maximise how well the model fits 
the data, thus allowing risk factors of URI incidence to be 
identified. However, machine learning approaches are optimised 
by evaluating the predictive accuracy of the model on unseen 
data, allowing the importance of different variables as predictors 
to be evaluated21. Recently, the use of machine learning 
techniques to predict adverse outcomes to the training process 
has been advocated22. However, when test samples are 
unbalanced (e.g. with low URI incidence), these methods can 
produce inaccurate results as the classification model produced 
may achieve high levels of overall accuracy by predicting the 
majority class (e.g. ‘not ill’) with high accuracy at the cost of 
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poor accuracy for the minority class (e.g. ‘ill’), rather than 
predicting both classes equally23. To resolve this issue, several 
bootstrapping methods have been identified. These methods 
create a balanced sample dataset by providing simulated data 
based on the statistical properties of the original dataset, thereby 
allowing machine learning techniques to provide accurate 
results24. This approach has not yet been considered within the 
s-IgA and URI literature in sport, so there is scope for its
introduction as a method of identifying the true relative 
importance and predictive ability of s-IgA with regards to URI 
incidence in youth athletes. 
Although the current literature suggests that s-IgA concentration 
may be a suitable short-term risk factor for URI incidence6 and 
that s-IgA secretion rate may be a more appropriate long-term 
risk factor of URI5, no study has evaluated the relative 
importance of these variables as predictors of URI onset at 
different time points prior to its occurrence  using data 
previously unseen by the model. Furthermore, the true predictive 
ability of s-IgA with regards to URI can be questioned5–7. 
Consequently, the aims of this study were to 1) identify the 
relative importance of s-IgA concentration and secretion rate at 
different timepoints in the four weeks prior to URI onset; and 2) 
identify the true predictive ability of s-IgA with regards to URI 
10 




Twenty-two youth athletes aged 16-18 years (age 16.8 ± 0.5 
years, height 173.3 ± 6.5 cm, body mass 70.1 ± 10.8 kg) 
participated in this study. Participants were recruited from a local 
independent school in the United Kingdom (UK), where they 
were members of the school's sport scholarship programme. 
Basketball (n=2), cricket (n=3), football (n=5), hockey (n=1), 
netball (n=5) and rugby union (n=6) were represented by sixteen 
males and six females competing at club/school (n=9), 
professional academy (n=4), county/regional (n=6) and 
international (n=3) standard in their respective sports. In total, 
participants took part in 10.5 ± 3.4 hours of sporting activity per 
week alongside their academic commitments of 8.30am-4pm. 
All participants were made aware of the benefits and risks of the 
study, and written informed consent was provided by all 
participants and their parents prior to the study. Ethics approval 
was granted by Leeds Beckett University Ethics Committee. 
Salivary IgA 
Over 38-weeks, between August and April, participants 
provided 15 saliva samples. Each sample was separated by two 
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weeks unless external factors (e.g. school holidays) dictated 
otherwise. Consequently, samples were collected three weeks 
apart twice and four weeks apart once. On each occasion, saliva 
samples were collected on the same weekday (Wednesday) 
within a 30-minute period, between 10:15 and 10:45. 
Participants provided samples prior to their first exercise of the 
day and following a 2-hour period without eating or drinking. 
Upon arrival, 50 ml of water was provided for participants to 
rinse out their mouths. Saliva sampling (via the passive drool 
method) commenced 10 minutes later. Participants were 
instructed to sit upright with their head tilted downwards and 
provide an unstimulated saliva sample of approximately 1.5 ml 
into a 3.5ml cryogenic vial. The volume of the sample and the 
time taken to produce it were recorded prior to freezing at -80˚C 
for storage within 30 minutes of completion. All standardisation 
and measurement methods mirrored those of previous studies5,6. 
Saliva samples were assessed in duplicate for s-IgA 
concentration by a service laboratory (ARU Biomarker 
Laboratory, Norwich, UK) using enzyme-linked immunosorbent 
assay in line with the manufacturer’s protocols (Secretory IgA 
EIA Kit Research, Catalogue Number 1-1602-SAL, Salimetrics 
LLC, State College, PA). S-IgA results were calculated as s-IgA 
concentration (µg/mL) and s-IgA secretion rate (s-IgA 
concentration divided by the time taken to provide the sample in 
minutes; µg/min). 
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In order to ensure that URI episodes were not systematically 
missed (e.g. through non-responding when ill if not at school), 
s-IgA samples were only included in analysis if a minimum
number of daily URI questions were completed before the next 
sampling time point. The thresholds for inclusion were 7/14 for 
two weeks, 10/21 for three weeks and 14/28 for four weeks. The 
between-day CV was calculated for s-IgA concentration and 
secretion rate from the thirteen participants who did not suffer 
from URI at either week 0 or 2.  
URI questionnaire 
Participants provided URI details seven days per week as part of 
their usual wellness monitoring programme. Details were 
provided using an online platform (Sports-train, Nice) similar to 
a previous study25. The question to report URI was: "Have you 
continuously experienced any of the following over the last 24 
hours? Sore throat, runny nose, cough, scratchy throat, nasal 
congestion, headache, fever, hoarseness, sneezing and/or body 
aches and pains (not related to delayed onset muscle soreness)?" 
based on previously identified symptoms of URI26 and similar to 
other self-report questions used within sport as part of wellness 
monitoring programmes27. Participants also identified the 
number of days the symptoms were present. URI episodes were 
only included in the analysis if a minimum of one symptom 
13 
persisted continuously for 72 hours or longer and were not 
considered to be recurrent (i.e. those URI episodes which began 
within seven days of the previous episode finishing6). Those URI 
episodes identified as occurring due to an allergy, established via 
discussion with the athlete in question, were also removed from 
analysis.  
Statistical analyses 
In order to assess the predictive ability of s-IgA with regards to 
URI, the collected data was split into three datasets. One 
evaluated URI incidence on the day of saliva sampling (URIday), 
one evaluated URI incidence within the 2 weeks following 
sampling (URI2wk) and one evaluated URI incidence within the 
4 weeks following sampling (URI4wk). These timings were 
chosen to best replicate a previous study considering deviations 
from the average healthy s-IgA concentration6, within the 
fortnightly sampling limitation of this study.  
Based on previous research, three features were included in each 
dataset for s-IgA concentration and secretion rate: the 
individual’s average healthy measure, the percentage deviation 
from the individual’s average healthy measure, and the raw value 
of the measure5,6. The individual’s average healthy measure was 
calculated by averaging all of his/her s-IgA concentration or 
secretion rate values over a minimum of four weeks before and 
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two weeks after URI incidence, matching as closely as possible 
to the three and one week periods previously used6. To account 
for other potential confounding variables, the three classification 
features of sport group, sex and environment were also added to 
the model. All three classification features had previously shown 
relationships with URI incidence28,29. Due to the small sample 
size for each sport, the sport group variable clustered athletes 
into court-based (basketball and netball), field-based (football 
and hockey), contact (rugby) and summer (cricket) sports. Sex 
split the athletes based on their sex (female for netball and 
hockey, male for all others), and environment split the sports into 
indoor (basketball and netball) or outdoor (all others) sports. The 
outcome variable was a binary URI or no URI. 
To establish the relative importance and predictive ability of s-
IgA concentration and secretion rate with regards to URI in 
youth athletes, the random forest machine learning algorithm 
was used. To provide a robust assessment of the predictive 
ability of the features in URI, URI2wk and URI4wk, 1000 trials 
were conducted. In each trial, new randomized, stratified 
samples were generated from the original datasets for the 
training (50%), validation (25%) and testing (25%) subsets and 
the random forest algorithm was run. The training subset was z-
score normalised and kernel smoothed bootstrapping24 was used 
to balance it, providing equal numbers of positive and negative 
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URI samples. Neither the validation nor the testing subsets were 
subjected to this resampling process. Both the training and 
validation subsets were used for parameter selection and the 
predictive ability of the models was assessed using the testing 
subset as a measure of out-of-sample predictive ability. The 
results are presented via box and whisker plots, which provide 
the median, interquartile range (IQR) and outlying results from 
the 1000 trials evaluated for each model. 
The relative feature importance was measured using the 
permutation method with mean decrease in accuracy reported as 
the metric for feature importance30. The mean decrease in 
accuracy is measured in arbitrary units (AU) and provides a 
relative measure of the importance for each feature to the 
performance of each model. A larger number is representative of 
a greater importance to the prediction of URI, but these values 
cannot be compared between models. The predictive ability of 
the models was evaluated using the area under the curve (AUC). 
The AUC is calculated based on the number of correct and 
incorrect predictions made by the model, providing a value 
between 0 and 1, where 0.5 indicates that the model has a 50% 
chance of predicting the right value. An AUC value greater than 
0.75 was used as the threshold for a good predictive model31. All 
analyses were completed using bespoke scripts in MATLAB 
version 9.4 (MathWorks, Natick, Massachusetts). 
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Results 
Of the 3,311 URI responses included in the study, 372 (11.2%) 
were classified as URI from 45 unique episodes. Participants 
reported a median of 2 URI episodes (range 0-7) and the average 
length of URI was 17 ± 18 days. The between-day CV was 
31.1% for s-IgA concentration and 61.7% for s-IgA secretion 
rate. 
Figures 1, 2 and 3 show the relative feature importance for the 
random forest models for URIday, URI2wk and URI4wk. The 
positive values of the features across all three models indicate 
that all features improved the predictive ability of the model. 
However, from URIday to URI4wk there is a clear difference in the 
relative importance of two key variables: the percentage 
deviation from average healthy s-IgA concentration and the 
average healthy secretion rate. For the URIday model, the 
percentage deviation from average healthy s-IgA concentration 
was the most important predictive feature (median relative 
importance 1.74, IQR 1.41-2.07), whereas for URI4wk, the 
average healthy secretion rate was most important (median 
relative importance 0.94, IQR 0.79-1.13). No feature was clearly 
more important than any other in URI2wk. Figure 4 provides the 
AUC for all models and shows that the median AUC is not 
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greater than the 0.75 practically meaningful threshold set in any 
of the models.  
**INSERT FIGURES 1, 2, 3 AND 4 AROUND HERE** 
Discussion 
The aims of this study were to 1) identify the relative importance 
of s-IgA concentration and secretion rate as predictors of URI at 
different timepoints in the four weeks prior to URI onset; and 2) 
identify the true predictive ability of s-IgA with regards to URI 
incidence in youth athletes. Using a prospective longitudinal 
research design, our findings demonstrate that the relative 
importance of s-IgA measures differs depending upon the time 
before URI onset. At URIday, the percentage deviation from the 
average healthy s-IgA concentration was the most important 
predictive feature of the model, whereas at URI4wk the average 
healthy s-IgA secretion rate was the most important. All features 
held similar importance in the URI2wk model. In terms of 
predictive ability, the AUC of all three models fell below the 
0.75 AU threshold for a good predictor indicating that s-IgA 
measures cannot be used to accurately predict URI at three 
individual time points within four weeks of the URI episode 
(URIday, URI2wk and URI4wk). 
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The key finding of this study is the differentiation between the 
importance of s-IgA concentration and s-IgA secretion rate as 
predictors of URI at different timepoints in the four weeks prior 
to URI onset. It has previously been shown that the percentage 
deviation from the average healthy s-IgA concentration 
transiently drops in the three weeks prior to URI6 and is 
significantly related with URI incidence on the day of URI4,6. 
Conversely, s-IgA secretion rate has previously shown a greater 
association with URI than s-IgA concentration over periods of 
four weeks and greater5. Our predictive models add further 
support to these differences by identifying the percentage 
deviation from the average healthy s-IgA concentration as the 
most important feature for URIday (median relative importance 
1.74, IQR 1.41-2.07), and the average healthy s-IgA secretion 
rate as the most important feature for URI4wk (median relative 
importance 0.94, IQR 0.79-1.13). However, at URI2wk there 
appears to be a crossover in the importance of the two measures 
and there is no feature which is clearly more important than any 
other. It is possible that this can also be explained by the 
previously established three-week transient drop in s-IgA 
concentration prior to URI incidence6. In that study, a significant 
difference in the percentage deviation from average healthy s-
IgA concentration was only observed when URI values were 
compared to four-weeks pre-incidence and measures of one and 
two weeks post-URI6. It is therefore possible that although the 
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percentage deviation from average healthy s-IgA concentration 
is important on the day of SRI, it may have little practical 
importance in the weeks leading up to it. Unfortunately, due to 
the fortnightly sampling employed in this study, we are unable 
to confirm the importance of the measure at one and three weeks 
prior to URI onset.  
The second notable finding of this study is that none of our 
models’ AUCs were greater than the 0.75 threshold set for a 
good predictive model of URI in youth athletes. This observation 
confirms that while s-IgA can be used as a risk factor for URI, it 
cannot predict URI incidence alone. Such a finding is perhaps 
unsurprising given the multifactorial risk factors of URI, 
including low energy availability, which can compromise 
immunity within two days32, poor sleep, which influences 
immune function via the hypothalamic-pituitary-adrenal axis33 , 
environmental conditions, such as sharing water bottles and 
exposure to foreign pathogens from team-mates28,34 and the 
individual’s stress/recovery balance28,34. However, the lack of 
predictive ability of immune measures with regards to URI may 
also be related to their poor reliability. Our results indicated that 
the between day CV was 31.1% for s-IgA concentration and 
61.7% for s-IgA secretion rate. With a between day CV of 
31.1%, a s-IgA concentration sample with a true value of 100 
µg/ml could hold values from 68.9-131.1 µg/ml based on the 
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test’s error. This wide variation in the potential values of s-IgA 
concentration observed relative to its true value limits its 
predictive ability as the observed value could be much greater or 
smaller than the true value, resulting in numerous false positive 
or negative predictions of URI. 
Although our manuscript uses novel and advanced machine 
learning based algorithms to identify the relative importance and 
true predictive ability of s-IgA with regards to URI incidence in 
youth athletes, the results are subject to limitations. The first of 
which is the lack of training load, sleep and psychological stress 
data, which could have explained some of the reductions in s-
IgA levels and, if accounted for, may have helped provide a more 
accurate predictive model. Secondly, the use of self-reported 
data may have influenced the accuracy of the prediction model. 
The wide range of URI lengths (17 ± 18 days) is potentially 
indicative of different participants having different individual 
thresholds for when they are suffering from symptoms, which 
may have had a negative effect on the predictive ability of the 
model. Finally, the sample should be considered. Although this 
study was conducted in youth athletes, it was necessary to 
compare the research to adult athletes based on the current state 
of the literature4–7. It is important to note that the different 
demands of the two cohorts outlined in the introduction 
(different psychological stressors and coping mechanisms8–10) 
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may ensure that comparison between the two cohorts proves 
unsuitable. Future studies should consider the true predictive 
ability of s-IgA with regards to URI using the machine learning 
based methods considered in this study to clarify whether there 
are any differences between the two cohorts. It should also be 
noted that this study used a small and unbalanced sample (16 
males, 6 females), which may have influenced the results. 
Despite these limitations, our novel statistical analyses have 
provided results of significant merit within this field.  
Practical applications 
The results of this study are important for practitioners 
considering the use of s-IgA measures as predictors of URI 
incidence. Previous correlation-based analyses have identified 
significant relationships between s-IgA concentration, s-IgA 
secretion rate and URI incidence5–7. However, although the 
relative importance of these measures within our analyses 
confirms their usefulness as risk factors for URI incidence at 
different timepoints in the lead up to incidence, the predictive 
ability of the models indicate that s-IgA cannot be used to predict 
URI onset in youth athletes. It is therefore pivotal that s-IgA 
measures are only considered as risk factors for URI incidence 
and should be considered alongside other risk factors such as the 
sport evaluated, life stressors, nutritional deficiencies and energy 
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availability28 when considering changes to an athlete’s training 
schedule.  
Conclusion 
This study is the first to use advanced machine learning 
techniques to provide a robust assessment of the relative 
importance and predictive ability of s-IgA with regards to URI 
in youth athletes. In summary, our results show that there is a 
differentiation in the roles of s-IgA concentration and secretion 
rate in the four weeks prior to URI incidence. The percentage 
deviation from the average healthy s-IgA concentration was 
identified as the most important feature in URIday, indicating it 
may be a useful short-term risk factor for URI incidence. 
However, its usefulness as a short-term risk factor in practice 
may be limited by its unclear importance relative to other 
features in URI2wk. The average healthy s-IgA secretion rate was 
identified as the most important feature in URI4wk, indicating that 
the athlete’s healthy s-IgA secretion rate could be taken as a 
useful long-term risk factor for URI. However, none of the 
models produced were capable of accurately predicting URI 
onset, limiting the use of any of the features measured to risk 
factors rather than true predictors of URI incidence. 
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Figure 1: Box and whisker feature importance plots for 
URIday. The box provides the median, lower and upper 
quartiles for the 1000 trials completed. The whisker extends 
to the minimum and maximum values, excluding outliers 
(denoted by crosses). NB: Conc = concentration; SR = 
secretion rate; s-IgA Conc Per Dev = percentage deviation 
from average healthy s-IgA concentration; s-IgA SR Per Dev 
= percentage deviation from average healthy s-IgA secretion 
rate. 
30 
Figure 2: Box and whisker feature importance plots for 
URI2wk. The box provides the median, lower and upper 
quartiles for the 1000 trials completed. The whisker extends 
to the minimum and maximum values, excluding outliers 
(denoted by crosses). NB: Conc = concentration; SR = 
secretion rate; s-IgA Conc Per Dev = percentage deviation 
from average healthy s-IgA concentration; s-IgA SR Per Dev 
= percentage deviation from average healthy s-IgA secretion 
rate. 
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Figure 3: Box and whisker feature importance plots for 
URI4wk. The box provides the median, lower and upper 
quartiles for the 1000 trials completed. The whisker extends 
to the minimum and maximum values, excluding outliers 
(denoted by crosses). NB: Conc = concentration; SR = 
secretion rate; s-IgA Conc Per Dev = percentage deviation 
from average healthy s-IgA concentration; s-IgA SR Per Dev 
= percentage deviation from average healthy s-IgA secretion 
rate. 
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Figure 4: Box and whisker plots for the AUC of each model. 
The box provides the median, lower and upper quartiles for 
the 1000 trials completed. The whisker extends to the 
minimum and maximum values, excluding outliers (denoted 
by crosses). Dashed line represents 0.75 AU threshold for 
good predictor. 
